Financial Review: Modular Medical (MODD) versus The Competition

Modular Medical (OTC:MODD – Get Rating) is one of 223 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare Modular Medical to similar businesses based on the strength of its risk, institutional ownership, earnings, analyst recommendations, valuation, profitability and dividends.

Institutional & Insider Ownership

14.7% of Modular Medical shares are owned by institutional investors. Comparatively, 47.0% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 59.2% of Modular Medical shares are owned by insiders. Comparatively, 14.7% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Modular Medical and its peers gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Modular Medical	N/A	-$18.63 million	-1.29
Modular Medical Competitors	$1.10 billion	$81.57 million	11.20

Modular Medical’s peers have higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Modular Medical and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-264.13%	-179.46%
Modular Medical Competitors	-1,355.92%	-145.04%	-26.44%

Analyst Recommendations

This is a summary of recent recommendations and price targets for Modular Medical and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	0	0	2	0	3.00
Modular Medical Competitors	881	3395	7583	172	2.59

Modular Medical currently has a consensus price target of $9.50, suggesting a potential upside of 281.53%. As a group, “Surgical & medical instruments” companies have a potential upside of 22.74%. Given Modular Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Modular Medical is more favorable than its peers.

Summary

Modular Medical peers beat Modular Medical on 7 of the 12 factors compared.

Modular Medical Company Profile

(Get Rating)

Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.